Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KIAA00895L pseudogene 1 (KIAA0895LP1) is classified as a **unitary pseudogene**, meaning it is a genomic DNA sequence similar to a protein-coding gene but is nonfunctional due to mutations or truncations[1]. Pseudogenes do not encode proteins, and KIAA0895LP1 has no known role as a therapeutic target, receptor, enzyme, transporter, or related molecular entity. There is currently no evidence that KIAA00895L pseudogene 1 is functionally active or involved in disease. While some pseudogenes can regulate gene expression by acting as competitive endogenous RNAs or decoys for microRNAs, there are no reports describing such functions for KIAA0895LP1 specifically[2][3]. Pseudogenes like KIAA0895LP1 are studied largely as genomic elements with potential but not established regulatory or pathogenic functions. This molecule does not appear to be a direct drug target, nor is it associated with clinical pharmacology, biomarker usage, or safety concerns[1][2][3]. **Note:** - This entry is **not a therapeutic target**; it is a pseudogene, and no pharmacological or mechanistic data or disease associations are available for it. - The abbreviation appears to include a likely typographical error in the query: "KIAA00895L" (with a double zero) should be "KIAA0895L" (with a zero and an eight), as reflected in the major genetic databases[1]. - The correct abbreviation is **KIAA0895LP1**; no indications suggest otherwise[1]. - There is no additional structured or functional information available for this pseudogene in major bioinformatics resources as of this search[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KIAA00895L pseudogene 1 (KIAA0895LP1).